Up next

Autoplay

Safety of PD-1 Inhibitors in Squamous Non-Small Cell Lung Cancer

2 Views • 07/14/23
Share
Embed
administrator
administrator
Subscribers
0

The panelists, Benjamin Levy, MD; Edward S. Kim, MD, FACP; and Paul K. Paik, MD, identify patients with squamous non-small cell lung cancer who may benefit from immune checkpoint inhibitors and the management of any related toxicity.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay